Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 286-292

  Chaichana, Kaisorn L ^a   Kosztowski, Thomas ^a   Niranjan, Ashwi N I ^a   Olivi, Alessandro ^a   Weingart, Jon D ^a   Laterra, John ^a   Brem, Henry ^a   Quiñones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplastic astrocytoma; Contrast enhancement; Outcome; Recurrence; Survival

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CRANIOTOMY; DISEASE FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HEMISPHERIC DOMINANCE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CONTRAST MEDIA; CRANIOTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77955627364     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.2.JNS091010     Document Type: Article

References (24)

1. Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, et al: Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15:2887-2893, 2008
2. Byrne TN: Imaging of gliomas. Semin Oncol 21:162-171, 1994
3. Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A: Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res 31:931-939, 2009
4. Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38:1371-1374, 1988
5. Donahue MJ, Lu H, Jones CK, Edden RA, Pekar JJ, van Zijl PC: Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med 56:1261-1273, 2006
6. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF: The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436-440, 1998
7. Hua J, Donahue MJ, Zhao JM, Grgac K, Huang AJ, Zhou J, et al: Magnetization transfer enhanced vascular-space-occupancy (MT-VASO) functional MRI. Magn Reson Med 61: 944-951, 2009
8. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, et al: Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg 105:34-40, 2006
9. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G III, Erickson RK, Hekmatpanah J, et al: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41:1028-1038, 1997
10. Laramore GE, Martz KL, Nelson JS, Griffin TW, Chang CH, Horton J: Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? Int J Radiat Oncol Biol Phys 17:1351-1356, 1989
11. Lu H, Pollack E, Young R, Babb JS, Johnson G, Zagzag D, et al: Predicting grade of cerebral glioma using vascular-space occupancy MR imaging. AJNR Am J Neuroradiol 29:373-378, 2008
12. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009
13. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, et al: Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol 9:113-123, 2007
14. Neyns B, Chaskis C, Joosens E, Menten J, D'Hondt L, Branle F, et al: A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma. Cancer Invest 26:269-277, 2008
15. Nomiya T, Nemoto K, Kumabe T, Takai Y, Yamada S: Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases. J Neurosurg 106:575-581, 2007
16. Ohgaki H, Biernat W, Reis R, Hegi M, Kleihues P: Gliosarcoma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System, ed 2. Lyon: IARC Press, 2000, pp 42-44
17. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF: MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26: 2466-2474, 2005
18. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, et al: Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol 27:579-584, 2009
19. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23:3-8, 1992
20. Salmaggi A, Fariselli L, Milanesi I, Lamperti E, Silvani A, Bizzi A, et al: Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol 255:171-177, 2008
21. Stupp R, Reni M, Gatta G, Mazza E, Vecht C: Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol 63:72-80, 2007
22. Tortosa A, Viñolas N, Villà S, Verger E, Gil JM, Brell M, et al: Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97: 1063-1071, 2003
23. Uh J, Lewis-Amezcua K, Martin-Cook K, Cheng Y, Weiner M, Diaz-Arrastia R, et al: Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity. Neurobiol Aging [epub ahead of print], 2009
24. Xu F, Ge Y, Lu H: Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62:141-148, 2009